Skip to content

Predicting LogP values using multi-strategy Graph Neural Networks: a complementary approach to protein-based biomarker discovery in cancer research

Oct 2026 · Iran Journal of Computer Science · Vol 9 · 0 citations · 41 references
Computational Drug Discovery Methods

TL;DR

This study proposes a new approach termed the Multi-Strategy Message Passing Graph Neural Network (MS-MPGN), which combines two complementary strategies: one that maps the overall shape of a molecule and another that focuses on local chemical interactions.

View source

Similar papers

Conference Open access Oct 2026

Lightweight Graph Network for Efficient and Interpretable Cancer Drug Response Prediction

Accurate prediction of cancer drug response is essential for advancing precision oncology; however, existing deep learning approaches, particularly graph neural networks (GNNs), often rely on computationally intensive architectures and lack interpretability, limiting their applicability in real-world clinical settings....

A. Rangesh, G. Devika · 0 citations
Open access Oct 2026

SADRP: A structurally aware multi-modal framework for drug response prediction

Motivation Predicting drug sensitivity across diverse cancer samples is a fundamental challenge in personalized therapy and drug discovery. This task requires comprehensive characterization of both drug and cancer cell line features. Current approaches often fail to fully capture the complex structural characteristics...

Ren Qi, Shu-Jia Liu, Tian-Hong Quan et al. · 0 citations
Open access Oct 2026

A benchmark study comparing deep learning and path analysis approaches for multi-class link prediction on a disease-specific literature knowledge graph.

Identifying and understanding multi-type drug-drug interactions and their associated toxicities is crucial for preventing adverse outcomes, especially in vulnerable populations, such as cancer patients, who may already have compromised health statuses. This paper provides a benchmark study that compares various commonl...

Marios Vottas, Konstantinos Bougiatiotis, Fotis Aisopos et al. · 0 citations
Open access Sep 2026

Heterogeneous Graph Contrastive Learning for Drug-Gene-Disease Motif Prediction

Drug repurposing and target discovery offer critical strategies for advancing therapeutic development by uncovering the potential biological pathways and novel associations among drugs, genes, and diseases. However, experimental discovery remains expensive and time-consuming, which limits the scalability of large-scale...

Hong-Sheng Xie, Yuan Gao, S. Ke et al. · 0 citations
Review Sep 2026

Advances in Machine Learning for Drug Repurposing: From Methodologies to Precision Medicine with Case Studies in COVID-19, Parkinson's Disease, and Cancer.

This review investigates recent advances in machine learning (ML) for drug repurposing, with applications spanning COVID-19, Parkinson's disease, and cancer. We provide a methodological taxonomy of ML techniques including supervised learning (e.g., random forests, SVMs), unsupervised clustering and dimensionality reduc...

Betel Gurara, Saron Gebremichael, Hana Sheto et al. · 0 citations

Related blog posts

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.